TFX Teleflex Inc

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, announced today the launch of the Comfort Flo® Plus High Flow Nasal Cannula. This new product addition expands the company’s portfolio of Heated High Flow Nasal Cannula Therapy (HFNCT) solutions and is designed to enhance patient comfort.

Inspired by the physicians and clinicians who help develop our products, the Comfort Flo® Plus Cannula is designed to enhance the overall patient experience by offering silicone nares, an optional chin strap to encourage closed mouth treatments, which may increase positive end pressure (PEP)3, and a bifurcated head strap for a secure fit during patient movement.

“Teleflex is dedicated to connecting clinicians with technology that helps improve patient outcomes and advances respiratory care,” said James Ferguson, President of the Respiratory Division at Teleflex. “The addition of the Comfort Flo® Plus Cannula supports the growing utilization of High Flo Nasal Cannula Therapy and further demonstrates our commitment to developing products that improve the quality of people’s lives.”

HFNCT has been shown to improve pulmonary compliance, reduce work of breathing and wash out dead space leading to improved fraction of alveolar gases.1 A new study from The New England Journal of Medicine suggests treatment with HFNCT can improve survival rates among patients with Acute Hypoxemic Respiratory Failure compared to treatment with standard Oxygen Masks or Non-Invasive Ventilation.2

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck® – trusted brands united by a common sense of purpose.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex, the Teleflex logo, Arrow, Deknatel, Hudson RCI, LMA, Pilling, Rusch, Weck and Comfort Flo are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries.© 2015 Teleflex Incorporated. All rights reserved. MC-001752

   

References:

1.   Dysart K, Miller TL, et al. Research in High Flow Therapy: Mechanisms of Action. Respiratory Medicine 2009 103, 1400 – 1405    

i. Cited in support of HFNC benefits, excluding CPAP. The Comfort Flo Humidification System is not intended for use as a CPAP device.

2. Frat JP, Thille AW, Mercat A, et al. High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure. The New England Journal of Medicine 2015: DOI: 10.1056/NEJMoa1503326 3. Hirst KR, Patel A, Vines DL. Evaluation of Bronchial Pressures and Tidal Volume Using Three Different Adult High Flow Nasal Cannula (HFNC) Devices. AARC 2011 Open Forum # 13 Presentation.

i. Cited in support of PEP effect only

 

View source version on businesswire.com: http://www.businesswire.com/news/home/20151027005015/en/

Teleflex IncorporatedJake ElguiczeTreasurer and Vice President, Investor Relations610-948-2836